SINOVAC regains Nasdaq compliance after filing annual report Jun 15, 2026 06:01AM
SINOVAC extends deadline for special dividend payment instructions May 21, 2026 06:30AM
Sinovac Biotech (SVA) Announces Nasdaq Hearings Panel Grants Continued Listing Jan 22, 2026 06:00AM
SINOVAC updates board composition and changes auditors Jan 5, 2026 05:47AM
Antigua court grants interim order on SINOVAC board composition Dec 17, 2025 07:00AM


Nov 18, 2025 03:01PM SINOVAC receives Nasdaq delisting notice, plans to appeal
Nov 11, 2025 05:01PM Sinovac shareholder group pushes for $19 dividend payment
Oct 24, 2025 10:30AM SINOVAC appoints UHY LLP as independent auditor to meet NASDAQ requirements
Jul 11, 2025 04:21PM SINOVAC board disputes validity of July 8 shareholder meeting
Jul 9, 2025 12:35PM SINOVAC board disputes shareholder meeting results amid legal fight
Jul 9, 2025 12:29PM SINOVAC begins paying $55 special dividend to shareholders
Jun 30, 2025 06:32AM Sinovac's (SVA) Board Urges Shareholders to Vote the WHITE Proxy Card “AGAINST” the Misguided Proposals to Remove SINOVAC’s Current Board
Jun 17, 2025 01:52PM Sinovac Biotech (SVA) Board Provides Update on Special Dividend Payment and Commitment to Delivering Value to All Shareholders
Jun 11, 2025 08:33AM Vivo Capital Issues Letter to Sinovac (SVA) Shareholders Addressing the Company’s False and Misleading Claims
Mar 28, 2025 07:01AM Sinovac Biotech (SVA) Announces New Board Member and Chairman of the Audit Committee
Mar 20, 2025 11:06AM Heng Ren Partners Demands Sinovac (SVA) Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading
Feb 28, 2025 07:00AM Sinovac Biotech (SVA) Announces New Board Pursuant to Privy Council Judgment and Order
Jan 16, 2025 08:02AM Sinovac Biotech (SVA) Issues Statement Regarding Privy Council Judgment
Aug 12, 2024 07:50AM Sinovac Biotech (SVA) Announces Appointment of New CEO